Literature DB >> 22371249

Basic research: an oral cyclic peptide drug to reverse kidney fibrosis?

Susan J Allison.   

Abstract

Entities:  

Year:  2012        PMID： 22371249     DOI： 10.1038/nrneph.2012.26

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.

Authors:  Hikaru Sugimoto; Valerie S LeBleu; Dattatreyamurty Bosukonda; Peter Keck; Gangadhar Taduri; Wibke Bechtel; Hirokazu Okada; William Carlson; Philippe Bey; Mary Rusckowski; Björn Tampe; Desiree Tampe; Keizo Kanasaki; Michael Zeisberg; Raghu Kalluri
Journal:  Nat Med       Date:  2012-02-05       Impact factor: 53.440
  1 in total
  1 in total

Review 1.  Strategies for the development of conotoxins as new therapeutic leads.

Authors:  Ryan M Brady; Jonathan B Baell; Raymond S Norton
Journal:  Mar Drugs       Date:  2013-06-28       Impact factor: 5.118
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.